Abiomed, Inc.ABMDNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P74
Within normal range
vs 2Y Ago
2.4x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2022 | 95.00% |
| Q2 2022 | -9.77% |
| Q1 2022 | 31.68% |
| Q4 2021 | -19.20% |
| Q3 2021 | 311.86% |
| Q2 2021 | -146.83% |
| Q1 2021 | -8.03% |
| Q4 2020 | -0.72% |
| Q3 2020 | 39.39% |
| Q2 2020 | 39.44% |
| Q1 2020 | -53.59% |
| Q4 2019 | 427.59% |
| Q3 2019 | -85.28% |
| Q2 2019 | 20.12% |
| Q1 2019 | 64.00% |
| Q4 2018 | -9.91% |
| Q3 2018 | -45.05% |
| Q2 2018 | 143.37% |
| Q1 2018 | 176.67% |
| Q4 2017 | -46.43% |
| Q3 2017 | -34.12% |
| Q2 2017 | 150.00% |
| Q1 2017 | -5.56% |
| Q4 2016 | 71.43% |
| Q3 2016 | -30.00% |
| Q2 2016 | 15.38% |
| Q1 2016 | 4.00% |
| Q4 2015 | 38.89% |
| Q3 2015 | -14.29% |
| Q2 2015 | -91.25% |
| Q1 2015 | 674.19% |
| Q4 2014 | 244.44% |
| Q3 2014 | 310.77% |
| Q2 2014 | -147.44% |
| Q1 2014 | -18.18% |
| Q4 2013 | 266.67% |
| Q3 2013 | 167.42% |
| Q2 2013 | -144.50% |
| Q1 2013 | 46.84% |
| Q4 2012 | -51.36% |